Polypoidal Choroidal Vasculopathy and its effect after four months of treatment outcome- Case Report

Abstract

A 42-year-old female presented with moderate Non-proliferative diabetic retinopathy (NPDR) in both eyes, and the left eye hadpolypoidal choroidal Vasculopathy (PCV). The Optical coherence tomography (OCT) report of the left eye shows Pigment Epithelial Detachment (PED) with heterogeneous hyperreflectivity, which indicates the presence of polyps along with subretinal fluid collection. Initially, the patient was treated with an anti-VEGF injection of Ranibizumab. Afterward, there was no significant improvement in polyps regression and visual improvement. Then, three months of repeated anti-VEGF injections of Brolucizumab were given as a treatment. After the follow-up with the patient, Oct reports show that there was a resolved subretinal fluid, and the size of the polyps also reduced, with a marked visual outcome obtained. This case shows that treatment for PCV with an anti-VEGF injection of Brolucizumab gave better results in the polyp regression and showed good visual improvement.